RTI Surgical, Inc. (NASDAQ:RTIX) Upgraded to Buy by Zacks Investment Research


The firm presently has a $6.25 price objective on the medical equipment provider's stock. Zacks Investment Research 's price objective would indicate a potential upside of 6.84% from the company's previous close.



from Biotech News